NL
MRNA icon

NVWM LLC’s Moderna MRNA Stock Holding History

NVWM LLC’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.68K Hold
24
– – ﹤0.01% 537
2026
Q1 		$1.22K Hold
24
– – ﹤0.01% 544
2025
Q4 		$708 Hold
24
– – ﹤0.01% 611
2025
Q3 		$620 Buy
24
+19
+380% +$530 ﹤0.01% 577
2025
Q2 		$138 Sell
5
-11
-69% -$290 ﹤0.01% 656
2025
Q1 		$454 Buy
16
+6
+60% +$213 ﹤0.01% 576
2024
Q4 		$416 Buy
+10
New +$478 ﹤0.01% 579
2024
Q3 		– Sell
-9,092
Closed -$1.08M – 672
2024
Q2 		$1.08M Sell
9,092
-84
-0.9% -$10.6K 0.29% 106
2024
Q1 		$978K Buy
9,176
+5,838
+175% +$588K 0.27% 117
2023
Q4 		$332K Sell
3,338
-306
-8% -$25.7K 0.1% 177
2023
Q3 		$376K Sell
3,644
-2,871
-44% -$320K 0.12% 167
2023
Q2 		$792K Buy
6,515
+2,403
+58% +$321K 0.26% 125
2023
Q1 		$632K Buy
+4,112
New +$678K 0.21% 141
2022
Q1 		– Sell
-23
Closed -$6K – 585
2021
Q4 		$6K Sell
23
-4,032
-99% -$1.18M ﹤0.01% 424
2021
Q3 		$1.56M Sell
4,055
-952
-19% -$351K 0.56% 43
2021
Q2 		$1.18M Buy
5,007
+100
+2% +$17.9K 0.42% 75
2021
Q1 		$643K Buy
4,907
+146
+3% +$21.2K 0.26% 140
2020
Q4 		$498K Sell
4,761
-10,542
-69% -$1.07M 0.21% 131
2020
Q3 		$1.08M Sell
15,303
-14
-0.1% -$976 0.51% 55
2020
Q2 		$983K Sell
15,317
-8,228
-35% -$451K 0.53% 58
2020
Q1 		$705K Buy
+23,545
New +$542K 0.49% 61

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

NVWM LLC's MRNA Position: Q2 2026 in Review

NVWM LLC held its Moderna (MRNA) position steady in Q2 2026 at 24 shares worth $1.68K. The position accounts for ﹤0.01% of the portfolio, ranked #537.

NVWM LLC first reported a position in MRNA in Q1 2020 and has held it in 21 quarters since. The position peaked at $1.56M in Q3 2021. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • NVWM LLC held 24 shares of Moderna worth $1.68K as of Q2 2026.
  • NVWM LLC left its Moderna share count unchanged in Q2 2026.
  • Moderna made up ﹤0.01% of NVWM LLC's portfolio in Q2 2026, its #537 holding.
  • NVWM LLC first reported a position in Moderna in Q1 2020 and has held it in 21 quarters since.
  • NVWM LLC's Moderna position peaked at $1.56M in Q3 2021.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on NVWM LLC's 13F filing for Q2 2026, filed 29 Jul 2026.